ACOG alphacognition.com Expected Profit
Alpha Cognition is moving toward the commercialization of its lead drug, establishing distribution networks in the US. The expected bottom line demonstrates an upward trend, where represents the current metric level. This growth is supported by the company's status as an innovator in Alzheimer's therapy and its expansion into the global neurology market through the creation of highly accessible medications for the elderly.
Analytical breakdowns and data insights for company Alpha Cognition Inc. (ACOG)
- share price and consensus valuation forecast:
- market capitalization data:
- company book value details:
- debt and solvency information:
Total Debt to Capital Alpha Cognition|ACOG - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Alpha Cognition Inc|ACOG - Aggregate Debt Obligations|Debts to Book Capitalization Alpha Cognition|ACOG - Company Long-Term Liabilities|Company Short-Term Debt Alpha Cognition|Quick Ratio alphacognition.com
- net income and valuation ratios data:
ACOG - Annual Net Income|Expected Profit Alpha Cognition|ACOG - Price to Earnings Multiple|Forward P/E Multiple Alpha Cognition Inc|ACOG - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Alpha Cognition|ACOG - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Alpha Cognition|ACOG - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months alphacognition.com|ACOG - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Alpha Cognition
Fundamental company valuation:Alpha Cognition, ACOG
Identifying fundamentally resilient assets requires an analysis of market expectations regarding future cash flows. This indicator captures the immediate market reaction to macroeconomics and news, measuring the balance between growth potential and the risk of overpayment, which, in the company's expected earnings, reflects the commercial prospects of the ALPHA-1062 drug for the treatment of Alzheimer's disease and cognitive disorders for Alpha Cognition (ACOG).
Analysis of competing companies
BIIB (Biogen Inc.) - Projected Future Earnings|Projected Future Earnings neurocrine.com|Expected Profit Regencell Bioscience Holdings Limited (RGC)|Expected Profit AXSM (Axsome)|Expected Profit ACADIA Pharmaceuticals Inc ACAD|XENE (Xenon Corp) - Forward Earnings|Viking Therapeutics - Projected Future Earnings|Expected Net Income SUPN (supernus.com)|CPRX: Projected Future Earnings|Denali (DNLI) - Projected Future Earnings|Future Profit HRMY|BHVN: Expected Net Income|Projected Future Earnings AMLX|Future Profit trevitherapeutics.com TRVI|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex (AVXL) - Expected Net Profit|CeriBell Corp - Projected Future Earnings|Projected Net Profit Prothena Corporation (PRTA)|alector.com (ALEC) - Expected Profit|Net Profit Forecast ANNX|OMER (Omeros Corp) - Projected Future Earnings|Neurogene Inc (NGNE) - Company Profit Forecast|Future Profit ACIU (AC Immune Corp)|Future Net Profit VYGR|Projected Future Earnings NMRA (Neumora Therapeutics)|Company Profit Forecast scilexholding.com (SCLX)|TVGN - Expected Profit|Expected Net Profit cogrx.com|Inhibikase (IKT) - Expected Profit|Net Profit Forecast SAVA|ASRT (Assertio Holdings) - Projected Future Earnings|Projected Future Earnings Coya|Projected Future Earnings VTGN|Future Profit ovidrx.com OVID|Expected Profit Acumen Pharma ABOS|CervoMed Corporation (CRVO) - Expected Net Profit|Alterity Therapeutics Ltd - Projected Future Earnings|Projected Net Profit Clene Inc. (CLNN)|pepgen.com (PEPG) - Expected Profit|Net Profit Forecast JUNS|RLMD (Relmada) - Projected Future Earnings|Expected Net Profit Annovis Bio Corporation ANVS|Future Profit GRCE (Grace Therapeutics, Inc.)|Projected Future Earnings fireflyneuro.com (AIFF)|Expected Profit Klotho Neurosciences KLTO|Expected Net Income NRSN|RVPH - Expected Profit|Expected Net Profit MetaVia Inc|NRXS: Projected Future Earnings|Helius Medical Technologies (HSDT) - Projected Future Earnings|Expected Profit Passage Bio Inc.|Expected Profit NEUP|Expected Profit Minerva Neurosciences Corp (NERV)|ATHA: Forward Earnings|Projected Future Earnings ADXN (Addex Therapeutics)|Expected Net Income ALZN|Cyclerion - Projected Future Earnings|PTIX - Projected Future Earnings|KTTA (pasitheaclinics.com) - Future Profit|Cortigent - Expected Net Income|ATXI (Avenue Therapeutics) - Projected Future Earnings|Future Profit brainstorm-cell.com (BCLI)|Expected Profit Cara Therapeutics (CARA)|CHRO - Expected Net Profit|Projected Future Earnings ELYM (Eliem Therapeutics Inc.)|Projected Net Profit Intra-Cellular Therapies Inc.|LBPH - Expected Profit|MRNS (marinuspharma.com) - Net Profit Forecast|NKGN: Projected Future Earnings|NRBO - Company Profit Forecast|Future Profit SAGE|SNPX (Synaptogenix, Inc) - Future Net Profit|Projected Future Earnings TRVN|Company Profit Forecast vigilneuro.com|Expected Profit Anew Medical, Inc. WENA|Cerevel Therapeutics Inc (CERE) - Expected Net Profit
